Quantcast

Latest Piperazines Stories

2014-08-19 23:02:22

The Firm is representing men and boys in Risperdal lawsuits who allegedly developed gynecomastia (male breast growth) due to their use of the atypical antipsychotic medication. New York, New York (PRWEB) August 19, 2014 As Risperdal lawsuits (http://www.risperdallawsuitcenter.com) mount in U.S. courts, Bernstein Liebhard LLP notes the publication of a new study that suggests the use of atypical antipsychotic medications may increase the risk of acute kidney injury in elderly patients....

2014-08-14 12:27:26

Ameritox's Ingenuity Health introduces method to help assess medication adherence in patients prescribed Seroquel XR BALTIMORE, Aug. 14, 2014 /PRNewswire/ -- Ameritox(SM), the nation's leader in medication monitoring solutions, today launched a method to help assess medication adherence in behavioral health patients prescribed the antipsychotic drug Seroquel XR, one of the 40 best-selling medications in the U.S. This new method marks a critical step toward building a comprehensive...

2014-08-11 08:28:42

LONDON, August 11, 2014 /PRNewswire/ -- Avillion LLP, a co-developer of late-stage pharmaceutical assets, announces that the first patients have been dosed in the United States in a global Phase 3 clinical trial called "BFORE," which is designed to assess the effectiveness and safety of BOSULIF(R) (bosutinib) as a first-line treatment for patients with chronic phase Philadelphia chromosome positive (Ph+) chronic myelogenous leukemia (CML). The first patient was dosed on July...

2014-08-09 23:03:20

Risperdal Lawsuit Claims Continue to Be Filed Against Johnson & Johnson Contending Male Breast Growth Due to the Manufacturer’s Antipsychotic Drug Risperdal Reports Wright & Schulte LLC Columbus, OH (PRWEB) August 09, 2014 Risperdal lawsuits currently pending litigation in the Philadelphia Court of Common Pleas in Pennsylvania have grown to 662 Risperdal lawsuit claims filed against the makers of the antipsychotic drug, notes Wright & Schulte LLC. According to the court...

2014-08-08 08:26:35

First ADASUVE Launch in Latin America MOUNTAIN VIEW, Calif., Aug. 8, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced that ADASUVE(®) inhalation powder, pre-dispensed (loxapine) is now available in Guatemala. This approval represents the first ADASUVE approval in Latin America for Ferrer and Alexza. Ferrer is Alexza's commercial partner for ADASUVE in the EU, Latin America and Commonwealth of Independent States countries. Ferrer introduced ADASUVE during a...

2014-08-05 08:33:13

Peer-Reviewed Case Study from Fox Chase Cancer Center Demonstrates Value of Company's Unique Approach to Precision Medicine to Uncover Critical Treatment Insights IRVING, Texas, Aug. 5, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of precision medicine, announced today publication of a case study in which the company's comprehensive tumor profiling service, Caris Molecular Intelligence(TM), helped guide successful...

2014-07-30 12:30:25

PISCATAWAY, N.J., July 30, 2014 /PRNewswire/ -- InnoPharma, Inc. today announced the first generic launch of Olanzapine for Injection, 10mg/vial (the generic equivalent of Zyprexa® injection), in Canada. Olanzapine is indicated for the rapid control of agitation and disturbed behaviors in patients with schizophrenia or bipolar I mania. As the developer of this generic injectable drug, InnoPharma has entered into an agreement with Sandoz Canada Inc., pursuant to which Sandoz Canada...

2014-07-27 12:20:59

LifeScienceIndustryResearch.com adds Latest Report on "Global and Chinese Vardenafil (CAS 224785-90-4) Industry, 2009-2019 Market Research Report" to its store. DALLAS, July 27, 2014 /PRNewswire-iReach/ -- This is a professional and in-depth market survey on Global and Chinese Vardenafil (CAS 224785-90-4) industry. The report firstly reviews the basic information of Vardenafil (CAS 224785-90-4) including its classification, application and manufacturing technology. The report then...

2014-07-24 23:10:39

The DrugNews Center is the largest source for prescription drug and medical device warnings, research and legal news. Visit http://www.DrugNews.net today. Chicago, IL (PRWEB) July 24, 2014 The prescription drug safety center DrugNews.net has added new research information to the site for patients who have taken popular erectile dysfunction drugs like Viagra. Following a recent study that found men who’d taken the drugs had a higher rate of skin cancer*, a new report offers an...

2014-07-17 23:04:12

LifeScienceIndustryResearch.com adds latest report on “Global and Chinese Sildenafil Citrate (CAS 171599-83-0) Industry, 2009-2019 Market Research Report” to its store. Inquire before buying this report at http://www.lifescienceindustryresearch.com/inquire-before-buying?rname=15625. Dallas, TX (PRWEB) July 17, 2014 This is a professional and in-depth market survey on Global and Chinese Sildenafil Citrate (CAS 171599-83-0) industry. The report firstly reviews the basic information of...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related